Covidien is now Medtronic Minimally Invasive Therapies

LEARN MORE

Critical Congenital Heart Defects and Pulse Oximetry Screening

Non-Accredited

  • ID246167

  • Download
    Web-Based
  • English
  • Non-Accredited

In September 2011, the United States Department of Health and Human Services approved adding screening for critical congenital heart defects (CCHDs) with pulse oximetry to the Recommended Uniform Screening Panel. Using Nellcor pulse oximetry has been shown to be a simple and economical tool to aid healthcare providers in CCHD screening. Download the recommended screening protocol here.